Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 1,434 | 1,806 | 1,338 | 943 | 709 |
| Cost of Goods | 37 | 37 | 29 | 60 | 76 |
| Gross Profit | 1,397 | 1,768 | 1,309 | 883 | 633 |
| Operating Expenses | 12,809 | 12,639 | 11,265 | 9,253 | 6,541 |
| Operating Income | -11,375 | -10,834 | -9,927 | -8,310 | -5,833 |
| Other Income | 372 | 880 | 1,219 | 1,281 | 1,031 |
| Pre-tax Income | -11,002 | -9,954 | -8,708 | -7,029 | -4,802 |
| Net Income Continuous | -11,002 | -9,954 | -8,708 | -7,029 | -4,802 |
| Net Income | $-11,002 | $-9,954 | $-8,708 | $-7,029 | $-4,802 |
| EPS Basic Total Ops | -0.14 | -0.13 | -0.11 | -0.09 | -0.07 |
| EPS Basic Continuous Ops | -0.14 | -0.13 | -0.12 | -0.09 | -0.07 |
| EPS Diluted Total Ops | -0.14 | -0.13 | -0.11 | -0.09 | -0.07 |
| EPS Diluted Continuous Ops | -0.14 | -0.13 | -0.12 | -0.09 | -0.07 |
| EBITDA(a) | $-11,126 | $-10,605 | $-9,714 | $-8,157 | $-5,710 |